These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 21956995)
61. Combining TGF-β signal inhibition and connexin43 silencing for iPSC induction from mouse cardiomyocytes. Dai P; Harada Y; Miyachi H; Tanaka H; Kitano S; Adachi T; Suzuki T; Hino H; Takamatsu T Sci Rep; 2014 Dec; 4():7323. PubMed ID: 25471520 [TBL] [Abstract][Full Text] [Related]
62. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes. Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478 [TBL] [Abstract][Full Text] [Related]
63. Generation and characterization of reprogrammed sheep induced pluripotent stem cells. Liu J; Balehosur D; Murray B; Kelly JM; Sumer H; Verma PJ Theriogenology; 2012 Jan; 77(2):338-46.e1. PubMed ID: 21958637 [TBL] [Abstract][Full Text] [Related]
64. MicroRNA Replacing Oncogenic Klf4 and c-Myc for Generating iPS Cells via Cationized Pleurotus eryngii Polysaccharide-based Nanotransfection. Deng W; Cao X; Chen J; Zhang Z; Yu Q; Wang Y; Shao G; Zhou J; Gao X; Yu J; Xu X ACS Appl Mater Interfaces; 2015 Sep; 7(34):18957-66. PubMed ID: 26269400 [TBL] [Abstract][Full Text] [Related]
66. Derivation of LIF-independent mouse iPS cells with modified Oct4. Hirai H; Firpo M; Kikyo N Stem Cell Res; 2015 Sep; 15(2):384-6. PubMed ID: 26318720 [TBL] [Abstract][Full Text] [Related]
67. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency. Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261 [TBL] [Abstract][Full Text] [Related]
68. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells. Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429 [TBL] [Abstract][Full Text] [Related]
69. Reprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cells. Wang WW; Wang W; Jiang Y; Han GF; Lu S; Li G; Zhang J Cytotherapy; 2013 May; 15(5):578-85. PubMed ID: 23415920 [TBL] [Abstract][Full Text] [Related]
70. An improved reprogrammable mouse model harbouring the reverse tetracycline-controlled transcriptional transactivator 3. Alaei S; Knaupp AS; Lim SM; Chen J; Holmes ML; Änkö ML; Nefzger CM; Polo JM Stem Cell Res; 2016 Jul; 17(1):49-53. PubMed ID: 27558603 [TBL] [Abstract][Full Text] [Related]
71. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells. Febbraro F; Chen M; Denham M Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617 [TBL] [Abstract][Full Text] [Related]
72. Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes. Jiang B; Dong H; Li Q; Yu Y; Zhang Z; Zhang Y; Wang G; Zhang Z Cell Biochem Biophys; 2013 Jun; 66(2):309-18. PubMed ID: 23212180 [TBL] [Abstract][Full Text] [Related]
73. Generation of Induced Pluripotent Stem Cells in Rabbits. Afanassieff M; Tapponnier Y; Savatier P Methods Mol Biol; 2016; 1357():149-72. PubMed ID: 25413017 [TBL] [Abstract][Full Text] [Related]
74. Mouse-induced pluripotent stem cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for ischemic stroke therapy. Liu SP; Fu RH; Wu DC; Hsu CY; Chang CH; Lee W; Lee YD; Liu CH; Chien YJ; Lin SZ; Shyu WC Stem Cells Dev; 2014 Feb; 23(4):421-33. PubMed ID: 24266622 [TBL] [Abstract][Full Text] [Related]
75. Generation of pig iPS cells: a model for cell therapy. Montserrat N; Bahima EG; Batlle L; Häfner S; Rodrigues AM; González F; Izpisúa Belmonte JC J Cardiovasc Transl Res; 2011 Apr; 4(2):121-30. PubMed ID: 21088946 [TBL] [Abstract][Full Text] [Related]
77. Generation of Mouse-Induced Pluripotent Stem Cells by Lentiviral Transduction. Liu X; Chen J; Firas J; Paynter JM; Nefzger CM; Polo JM Methods Mol Biol; 2019; 1940():63-76. PubMed ID: 30788818 [TBL] [Abstract][Full Text] [Related]
78. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition. Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769 [TBL] [Abstract][Full Text] [Related]
79. Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions. Qu X; Liu T; Song K; Li X; Ge D PLoS One; 2012; 7(10):e48161. PubMed ID: 23110200 [TBL] [Abstract][Full Text] [Related]
80. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs). Greder LV; Post J; Dutton JR Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]